Nir Nimrodi
First SEC filing: March 18, 2026 · Latest: March 18, 2026
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 4, 2026 | EVGN | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 4, 2019 | PGEN | A | 75,758 | · | · | 75,758 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 4, 2019 | PGEN | A | 13,774 | · | · | 19,482 Direct | +241.31% | Acquired | (price as of 2026-10-02) |
| Jan. 3, 2019 | PGEN | S 10b5-1 | 4,058 | $7.07 | $28,690 | 5,708 Direct | -41.55% | Disposed | 20.8% (price as of 2026-10-02) |
| Jan. 2, 2019 | PGEN | M | 9,766 | · | · | 29,297 Direct | -25.00% | Disposed | (price as of 2026-10-02) |
| Jan. 2, 2019 | PGEN | M | 9,766 | · | · | 9,766 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 2, 2018 | PGEN | A | 39,063 | · | · | 39,063 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 11, 2017 | PGEN | P | 3,369 | $18.75 | $63,169 | 7,369 Indirect | +84.23% | Acquired | -54.5% (price as of 2026-10-02) |
| Aug. 29, 2016 | PGEN | P | 4,000 | $26.12 | $104,480 | 4,000 Indirect | · | Acquired | -67.3% (price as of 2026-10-02) |
| March 17, 2014 | PGEN | A | 1,000,000 | · | · | 1,000,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 4, 2026 | EVGN | Stock Option (right to buy) | Ordinary Shares | · | Sept. 4, 2036 | 10,000 | Acquired |
| Jan. 4, 2019 | PGEN | Restricted Stock Units | Common Stock | · | · | 75,758 | Acquired |
| Jan. 2, 2019 | PGEN | Restricted Stock Units | Common Stock | · | · | 9,766 | Disposed |
| Jan. 2, 2018 | PGEN | Restricted Stock Units | Common Stock | · | · | 39,063 | Acquired |
| March 17, 2014 | PGEN | Option to Purchase Common Stock | Common Stock | $29.95 | March 17, 2024 | 1,000,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 7 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| March 18, 2026 | EVGN | Stock Option (right to buy ordinary shares) | 5,625 | Direct |
| March 18, 2026 | EVGN | Stock Option (right to buy ordinary shares) | 1,800 | Direct |
| March 18, 2026 | EVGN | Stock Option (right to buy ordinary shares) | 1,800 | Direct |
| March 18, 2026 | EVGN | Stock Option (right to buy ordinary shares) | 1,800 | Direct |
| March 18, 2026 | EVGN | Stock Option (right to buy ordinary shares) | 10,000 | Direct |
| Feb. 10, 2025 | ODYS | Options to purchase common stock (right to buy) | 30,000 | Direct |
| Feb. 10, 2025 | ODYS | Options to purchase common stock (right to buy) | 15,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | $136,591 | · | · | · | · | · | $825,621 | $1,621,215 |
| 2018 | $515,000 | $100,000 | · | · | · | · | $21,636 | $1,162,815 |
| 2016 | $500,000 | · | · | · | · | · | $20,948 | $520,948 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.